Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Zeitschrift Fur Medizinische Physik
|
December 18, 2019
The superficially averaged dose gradient at the target volume's boundary: A two-dimensional formulation and solution of anisotropic dose gradient problems
Markus Wösle
BMC Cancer
|
September 19, 2020
Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model
Christian Linke, Markus Wösle, Anja Harder
Physics and Imaging in Radiation Oncology
|
January 18, 2021
Optimizing radiosurgery with photons for ocular melanoma
I Frank Ciernik, Markus Wösle, Lothar Krause, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
September 7, 2021
Feasibility of aponeurectomy in combination with perioperative <sup>192</sup>Ir high dose rate brachytherapy for Dupuytren's disease
I Frank Ciernik, Philipp Goldschmidt, Markus Wösle, et al.
International Ophthalmology
|
January 11, 2025
Ruthenium-106 brachytherapy and central uveal melanoma
Luise Grajewski, Christiane Kneifel, Markus Wösle, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 18, 2018
Stereotactic radiotherapy for choroidal melanomas by means of HybridArc™ : Physics and technique of linac-based photon beam therapy
Markus Wösle, Lothar Krause, Shanthala Sreenivasa, et al.
Ocular Oncology and Pathology
|
September 3, 2024
Adjuvant Brachytherapy with Ruthenium-106 to Reduce the Risk of Recurrence of Conjunctival Melanoma after Excision
Luise Grajewski, Christiane Kneifel, Markus Wösle, et al.
The British Journal of Ophthalmology
|
March 9, 2023
Impact of tumour volume and treatment delay on the outcome after linear accelerator-based fractionated stereotactic radiosurgery of uveal melanoma
Shanthala Sreenivasa, Markus Wösle, Yann Gager, et al.
Molecular & Cellular Oncology
|
September 26, 2025
Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor
Sandra Leisz, Antonio Pelligrino, Saskia Fritzsche, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Zeitschrift Fur Medizinische Physik
|
December 18, 2019
The superficially averaged dose gradient at the target volume's boundary: A two-dimensional formulation and solution of anisotropic dose gradient problems
Markus Wösle
BMC Cancer
|
September 19, 2020
Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model
Christian Linke, Markus Wösle, Anja Harder
Physics and Imaging in Radiation Oncology
|
January 18, 2021
Optimizing radiosurgery with photons for ocular melanoma
I Frank Ciernik, Markus Wösle, Lothar Krause, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
September 7, 2021
Feasibility of aponeurectomy in combination with perioperative <sup>192</sup>Ir high dose rate brachytherapy for Dupuytren's disease
I Frank Ciernik, Philipp Goldschmidt, Markus Wösle, et al.
International Ophthalmology
|
January 11, 2025
Ruthenium-106 brachytherapy and central uveal melanoma
Luise Grajewski, Christiane Kneifel, Markus Wösle, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 18, 2018
Stereotactic radiotherapy for choroidal melanomas by means of HybridArc™ : Physics and technique of linac-based photon beam therapy
Markus Wösle, Lothar Krause, Shanthala Sreenivasa, et al.
Ocular Oncology and Pathology
|
September 3, 2024
Adjuvant Brachytherapy with Ruthenium-106 to Reduce the Risk of Recurrence of Conjunctival Melanoma after Excision
Luise Grajewski, Christiane Kneifel, Markus Wösle, et al.
The British Journal of Ophthalmology
|
March 9, 2023
Impact of tumour volume and treatment delay on the outcome after linear accelerator-based fractionated stereotactic radiosurgery of uveal melanoma
Shanthala Sreenivasa, Markus Wösle, Yann Gager, et al.
Molecular & Cellular Oncology
|
September 26, 2025
Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor
Sandra Leisz, Antonio Pelligrino, Saskia Fritzsche, et al.
Page
of 1